Literature DB >> 32044163

Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.

Federica Sicca1, Donata Martinuzzi2, Emanuele Montomoli2, Anke Huckriede3.   

Abstract

Determination of influenza-specific antibody titers is commonly done using the hemagglutination inhibition assay (HAI) and the viral microneutralization assay (MN). Both assays are characterized by high intra- and inter-laboratory variability. The HAI assay offers little opportunity for standardization. For the MN assay, variability might be due to the use of different assay protocols employing different readouts. We therefore aimed at investigating which of the MN assay readout methods currently in use would be the most suitable choice for a standardized MN assay that could serve as a substitute for the HAI assay. For this purpose, human serum samples were tested for the presence of influenza specific neutralizing antibodies against A/California/7/09 H1N1 (49 sera) or A/Hong Kong/4801/2014 (50 sera) using four different infection readout methods for the MN assay (cytopathic effect, hemagglutination, ELISA, RT qPCR) and using the HAI assay. The results were compared by correlation analysis and by determining the level of agreement before and after normalization to a standard serum. Titers as measured by the 4 MN assay readouts showed good correlation, with high Person's r for most comparisons. However, agreement between nominal titers varied with readouts compared and virus strain used. In addition, Pearson's correlation of MN titers with HAI titers was high but agreement of nominal titers was moderate and the average difference between the readings of two assays (bias) was virus strain-dependent. Normalization to a standard serum did not result in better agreement of assay results. Our study demonstrates that different MN readouts result in nominally different antibody titers. Accordingly, the use of a common and standardized MN assay protocol will be crucial to minimize inter-laboratory variability. Based on reproducibility, cost effectiveness and unbiased assessment of results we elected the MN assay with ELISA readout as most suitable for a possible replacement of the HAI assay.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Agreement; Assays standardization; Bland-Altman; Correlation; Hemagglutination inhibition assay; Microneutralization assay

Mesh:

Substances:

Year:  2020        PMID: 32044163     DOI: 10.1016/j.vaccine.2020.01.088

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program.

Authors:  Andrei Shanko; Marina Shuklina; Anna Kovaleva; Yana Zabrodskaya; Inna Vidyaeva; Aram Shaldzhyan; Artem Fadeev; Alexander Korotkov; Marina Zaitceva; Liudmila Stepanova; Liudmila Tsybalova; Larisa Kordyukova; Anton Katlinski
Journal:  Vaccines (Basel)       Date:  2020-12-12

2.  Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice.

Authors:  Ramil R Mintaev; Dina V Glazkova; Olga V Orlova; Elena V Bogoslovskaya; German A Shipulin
Journal:  Vaccines (Basel)       Date:  2022-03-29

3.  Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.

Authors:  Nidhi Mittal; Nayanika Sengupta; Sameer Kumar Malladi; Poorvi Reddy; Madhuraj Bhat; Raju S Rajmani; Koen Sedeyn; Xavier Saelens; Somnath Dutta; Raghavan Varadarajan
Journal:  Viruses       Date:  2021-08-27       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.